The results of the study also indicated that the level of serum NSE in patients with SLE was significantly higher compared to the control group, and the level of NSE was closely related to the SLEDAI score, suggesting that there was a certain degree of CNS damage in patients with SLE. The gene discussed is ENO2; the disease is systemic lupus erythematosus.